Remdesivir Injection and API Export Restriction Withdrawn, Now Freely Exportable

· Amphotericin-B Injections, Enoxaparin and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) also Freely Exportable

[DGFT Notification No. 56/2015-2020 dated 24 February, 2022]

Effect of this Notification: The export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), Amphotericin - B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under HS code as mentioned above or falling under any other HS code has been made 'Free' with immediate effect.

Subject: Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API)

S.O. (E) In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes following amendment in Notification No. 08/2015-20 dated 14.06.2021, Notification No. 07/2015-20 dated 01.06.2021 and Notification No. 50/2015-20 dated 10.01.2022 related to export of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API):

S.No	ITC HS Codes	Description	Existing Policy	Revised Policy
207AA	Ex 293499, Ex 300490	Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API)	Restricted	Free
207AB	Ex 30049029, Ex 30049099	Amphotericin - B Injections	Restricted	Free
207AE	Ex 2942, Ex 3001, Ex 3002	Enoxaparin (Formulation and API)	Restricted	Free
207AF	Ex 3002	Intra-Venous Immunoglobulin (IVIG) (Formulation and API)	Restricted	Free

(Issued from F. No. 0 l /91 /180/24/AM22/EC /E-27724)